MedTech Spectrum

Article Name Medical Devices & Implant

FDA Approves ProVee System, New Generation of Prostatic Urethral Stents

The ProVee System is a next-generation prostatic urethral stent designed to gently open up the obstructed prostate and relieve lower urinary tract symptoms associated with BPH

10th December, 2025

KIC Ventures Unveils VertiFix to Solve Growing Crisis in Interspinous Implant Revisions

KIC Ventures began educating physicians to use the InSpan instrumentation system to carefully dissect around interspinous implants and remove them with minimal disruption

02nd December, 2025

Neusoft Medical Systems Unveils World's First 8cm Wide-Coverage Photon-Counting CT

Neusoft Medical's latest high-end systems are gaining rapid global traction, with installations rising worldwide

02nd December, 2025

InsiteOne Announces Key Strategic Partnerships

InsiteOne expands enterprise imaging portfolio through strategic partnerships with ASCEND Cardiovascular and Apollo Enterprise imaging

01st December, 2025

Medtronic pioneers first AI-guided circular stapler for GI surgical use

The new system gives surgeons the first intelligent circular stapling option throughout the alimentary tract for the creation of end-to-end, end-to-side, and side-to-side anastomoses in both open and laparoscopic surgeries.

28th November, 2025

Brown’s Medical Imaging Merges with Prestige, Strengthening Nationwide Med-Tech & Medical Device Imaging Capabilities

The integration significantly strengthens Brown’s nationwide presence and enhances its ability to deliver responsive, reliable, and customer-first solutions across the United States.

27th November, 2025

AI, Automation, and Accuracy: Neocis Unveils the Next Evolution of Dental Robotics

The first and only FDA-cleared robotic system for dental implant surgery and now its next-generation evolution, Yomi S

24th November, 2025

SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart

Significant milestone reached in advancing a driverless total artificial heart, strengthening Picard Medicals leadership in total artificial heart technology

20th November, 2025

Mindray Introduces TE Air e5M Wireless Handheld Ultrasound to Revolutionise Whole-Body Scanning

This system reinforces Mindray's commitment to affordability by offering pioneering technology with no subscriptions or hidden fees

20th November, 2025

Lumenis Launches New Stellar M22 Skin Treatments Platform with XPL Technology

Stellar M22 offers over 30 different treatments for skin and hair removal, delivering safe and outstanding clinical results

19th November, 2025

Nanox Partners with 3DR Labs to Expand AI-Powered Imaging Solutions

3DR Labs to Offer Nanox.AI’s FDA-Cleared Imaging Solutions to Its Network of More Than 1,800 Hospitals and Imaging Centres Across the U.S.

19th November, 2025

Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants

Yomi S and YomiPlan AI Platform Now FDA-Cleared, Offering Unprecedented Precision, Efficiency, and Access for Dentists and Patients

18th November, 2025

A New Era for Removable Implant Dentistry: PreatLoc Debuts in the U.S.

A new attachment system designed to bridge the gap between clinical performance, patient comfort, and affordability

18th November, 2025

Kelyniam Global Secures U.S. License for Evonik's VESTAKEEP Fusion Biomaterial in Cranial Implants

The license enhances Kelyniam's regenerative product lineup by incorporating VESTAKEEP Fusion's osteoconductive properties

14th November, 2025

Channel Medsystems Surpasses 5,000 Cerene Cryotherapy Procedures, Marking Milestone in Women’s Health Innovation

The milestone reflects expanding adoption across hospitals, ambulatory surgery centres, and private OB/GYN practices nationwide

07th November, 2025

W&H Medical Unveils FDA-Cleared Piezo & Drill Combo Console for Rhinoplasty and Facial Surgery

Driven by high-frequency piezo technology, the console enables precise, tissue-sparing bone cutting while protecting nerves, vessels, and soft tissues

06th November, 2025

How Femasys Is Using Innovation to Rethink Permanent Birth Control

Designed as a safe, accessible, and office-based alternative to surgical sterilization, FemBloc represents a paradigm shift in permanent contraception

05th November, 2025

Femasys Secures FDA Approval to Advance Final FemBloc Trial Phase and $12Mn Financing

Successful completion of the first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward U.S. FDA approval

04th November, 2025